MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line modelsFrançois‐Xavier Mahon(Hammersmith Hospital), Junia V. Melo(Hammersmith Hospital)BloodFebruary 27, 200310.1182/blood.v101.6.2368Cited by 538SaveCiteExport RISWatch citationsRelated PapersTrough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia|Blood|2006|604Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells|Oncotarget|2015|21